SCHEMBL2952601

SCHEMBL2952601

COC(=O)c1oc2cccnc2c1NC(=O)[C@H]1CC[C@H](N2CCOCC2=O)CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ WNT3 P56703 2/20 0.38
▸ HSD17B10 Q99714 6/20 0.37
▸ TSHR P16473 3/20 0.37
▸ MEN1 O00255 4/20 0.37
▸ KMT2A Q03164 4/20 0.37
▸ ALDH1A1 P00352 4/20 0.37
▸ MAPT P10636 2/20 0.37
▸ ALOX15 P16050 2/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ HTT P42858 2/20 0.37
▸ HPGD P15428 1/20 0.37
▸ TNKS O95271 1/20 0.36
▸ TNKS2 Q9H2K2 1/20 0.36
▸ LMNA P02545 4/20 0.35
▸ DHODH Q02127 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ NPY5R Q15761 1/20 0.35
▸ TP53 P04637 1/20 0.34
▸ MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2952606 1.00 WNT3 (0.38) WNT3HSD17B10TSHRMEN1KMT2A
SCHEMBL13291326 0.88 NPY5R (0.45) WNT3HSD17B10TSHRMEN1KMT2A
SCHEMBL13879426 0.87 MAPT (0.56) HSD17B10TSHRMEN1KMT2AALDH1A1
SCHEMBL13290693 0.86 MEN1 (0.52) WNT3HSD17B10TSHRMEN1KMT2A
SCHEMBL2953862 0.86 MAPT (0.49) WNT3HSD17B10TSHRMEN1KMT2A
SCHEMBL2953860 0.86 MAPT (0.49) WNT3HSD17B10TSHRMEN1KMT2A
SCHEMBL13290828 0.86 MEN1 (0.45) WNT3HSD17B10TSHRMEN1KMT2A
SCHEMBL13290611 0.85 KMT2A (0.44) HSD17B10TSHRMEN1KMT2AALDH1A1
SCHEMBL13290909 0.84 POLB (0.54) HSD17B10TSHRMEN1KMT2AALDH1A1
SCHEMBL2949749 0.84 MEN1 (0.44) HSD17B10TSHRMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7737161-B2 Condensed furan compounds MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-06-15 — — US disclosed
US-7737161-B2 Condensed furan compounds MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-06-15 — — US disclosed
US-20090156803-A1 Condensed furan compounds KAWAGUCHI TAKAYUKI 2009-06-18 — — US disclosed
US-20090156803-A1 Condensed furan compounds KAWAGUCHI TAKAYUKI 2009-06-18 — — US disclosed
US-7514449-B2 Fused furan compound MITSUBISHI TANABE PHARMA CORPORATION (JP) 2009-04-07 — — US disclosed
US-7514449-B2 Fused furan compound MITSUBISHI TANABE PHARMA CORPORATION (JP) 2009-04-07 — — US disclosed
US-7514449-B2 Fused furan compound MITSUBISHI TANABE PHARMA CORPORATION (JP) 2009-04-07 — — US disclosed
US-20060094724-A1 Fused furan compound MITSUBISHI TANABE PHARMA CORPORATION (JP) 2006-05-04 — — US disclosed
EP-1582521-A1 FUSED FURAN COMPOUND TANABE SEIYAKU CO., LTD. (JP) 2005-10-05 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156803-A1 Condensed furan compounds F2, F12, F11 WNT3 4562/4885HSD17B10 943/4885TSHR 3368/4885
US-20060094724-A1 Fused furan compound F2, F12, F11 WNT3 4452/4885HSD17B10 810/4885TSHR 3045/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback